KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Q: What does CUSIP 483497103 represent in this 13F holders report?

CUSIP 483497103 is the security identifier for KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in Q1 2019?

67 institutional investors reported KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share for Q1 2019. Use the holders table for investor-level position and value details.

CUSIP: 483497103

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 50,580,036
Total 13F shares: 13,905,857
Share change: +697,056
Total reported value: $397,892,000
Price per share: $28.62
Number of holders: 67
Value change: +$23,850,655
Number of buys: 37
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2019
Previous quarter: Q4 2018

Recent filing periods for CUSIP 483497103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SV Health Investors, LLC	13F	Company	5%	2,548,202	$50,327,000	—	31 Dec 2018	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	2.8%	1,441,070	$28,461,000	—	31 Dec 2018	13F
Vivo Capital, LLC	13F	Company	2.7%	1,359,149	$26,843,000	—	31 Dec 2018	13F
VHCP Management III, LLC	13F	Company	2.5%	1,284,931	$25,377,000	—	31 Dec 2018	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.8%	900,000	$17,775,000	—	31 Dec 2018	13F
VHCP Management II, LLC	13F	Company	1.5%	759,181	$14,994,000	—	31 Dec 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.3%	650,000	$12,838,000	—	31 Dec 2018	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.2%	600,000	$11,850,000	—	31 Dec 2018	13F
Ghost Tree Capital, LLC	13F	Company	0.84%	425,000	$8,394,000	—	31 Dec 2018	13F
INTERWEST VENTURE MANAGEMENT CO	13F	Company	0.77%	388,766	$7,678,000	—	31 Dec 2018	13F
VANGUARD GROUP INC	13F	Company	0.67%	340,843	$6,732,000	—	31 Dec 2018	13F
Invesco Ltd.	13F	Company	0.55%	276,523	$5,461,000	—	31 Dec 2018	13F
BVF INC/IL	13F	Company	0.5%	252,693	$4,991,000	—	31 Dec 2018	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.63%	319,444	$4,954,000	—	31 Dec 2018	13F
Boxer Capital, LLC	13F	Company	0.4%	200,000	$3,950,000	—	31 Dec 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.35%	179,229	$3,540,000	—	31 Dec 2018	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.34%	173,000	$3,417,000	—	31 Dec 2018	13F
Samsara BioCapital, LLC	13F	Company	0.3%	150,000	$2,963,000	—	31 Dec 2018	13F
Broadfin Capital, LLC	13F	Company	0.28%	143,129	$2,827,000	—	31 Dec 2018	13F
Fosun International Ltd	13F	Company	0.27%	137,443	$2,444,000	—	31 Dec 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	83,881	$1,656,000	—	31 Dec 2018	13F
Polar Capital LLP	13F	Company	0.16%	78,900	$1,558,000	—	31 Dec 2018	13F
BARCLAYS PLC	13F	Company	0.12%	62,778	$1,240,000	—	31 Dec 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	60,000	$1,185,000	—	31 Dec 2018	13F
WEDGE CAPITAL MANAGEMENT L L P/NC	13F	Company	0.11%	54,511	$1,077,000	—	31 Dec 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	47,821	$944,000	—	31 Dec 2018	13F
BlackRock Finance, Inc.	13F	Company	0.09%	45,078	$891,000	—	31 Dec 2018	13F
Informed Momentum Co LLC	13F	Company	0.08%	41,896	$827,000	—	31 Dec 2018	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.08%	41,000	$810,000	—	31 Dec 2018	13F
NORTHERN TRUST CORP	13F	Company	0.08%	40,728	$805,000	—	31 Dec 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.07%	36,795	$727,000	—	31 Dec 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	34,519	$682,000	—	31 Dec 2018	13F
Laurion Capital Management LP	13F	Company	0.06%	30,201	$596,000	—	31 Dec 2018	13F
Telemetry Investments, L.L.C.	13F	Company	0.05%	24,883	$491,000	—	31 Dec 2018	13F
DAFNA Capital Management LLC	13F	Company	0.04%	20,225	$399,000	—	31 Dec 2018	13F
ALGERT GLOBAL LLC	13F	Company	0.04%	19,341	$382,000	—	31 Dec 2018	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.03%	17,551	$347,000	—	31 Dec 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.02%	11,967	$236,000	—	31 Dec 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.02%	11,133	$220,000	—	31 Dec 2018	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	4,532	$90,000	—	31 Dec 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	4,394	$87,000	—	31 Dec 2018	13F
FIRST QUADRANT LLC/CA	13F	Company	0.01%	3,054	$60,000	—	31 Dec 2018	13F
TIVERTON ASSET MANAGEMENT LLC	13F	Company	0%	2,512	$50,000	—	31 Dec 2018	13F
RAMSEY QUANTITATIVE SYSTEMS	13F	Company	0%	1,789	$35,000	—	31 Dec 2018	13F
Flinton Capital Management LLC	13F	Company	0%	1,292	$26,000	—	31 Dec 2018	13F
Tyers Asset Management LLC	13F	Company	0%	1,064	$21,000	—	31 Dec 2018	13F
Dorsey Wright & Associates	13F	Company	0%	862	$17,000	—	31 Dec 2018	13F
MORGAN STANLEY	13F	Company	0%	850	$17,000	—	31 Dec 2018	13F
Neuburgh Advisers LLC	13F	Company	0%	836	$17,000	—	31 Dec 2018	13F
Meadow Creek Investment Management LLC	13F	Company	0%	608	$12,000	—	31 Dec 2018	13F

Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2019

As of 31 Mar 2019, KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,905,857 shares. The largest 10 holders included SV Health Investors, LLC, RA CAPITAL MANAGEMENT, LLC, Vivo Capital, LLC, Polar Capital LLP, VHCP Management III, LLC, EVENTIDE ASSET MANAGEMENT, LLC, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and VHCP Management II, LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q1 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders

Q1 2019 holders

Holder diff

Investor	Q4 2018 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q4 2018 Value $	Q1 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.